GSK2878175
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSK2878175, covering 2018-07-24 to 2018-07-24. Get the full timeline:
Most recent: Clinical Trial Update: A First Time in Human Study to Investigate the Safety, Tolerability and Pharmacokinetics of Single & Repeat Escalating Doses of GSK2878175 in Healthy Subjects [Phase 1]